Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients

Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients

Anemia is a major complication of end-stage kidney disease (ESKD). Erythropoiesis-stimulating agents and intravenous (IV) iron are the current backbone of anemia treatment in ESKD. Iron overload induced by IV iron is a potential clinical problem in dialysis patients. We compared the pharmacokinetics...

Full description

Bibliographic Details
Main Authors: Guy Rostoker, Fanny Lepeytre, Myriam Merzoug, Mireille Griuncelli, Christelle Loridon, Ghada Boulahia, Yves Cohen
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Pharmaceutics
Subjects:
pharmacokinetics
biodistribution
intravenous iron
iron sucrose
ferric carboxymaltose
iron isomaltoside
Online Access:https://www.mdpi.com/1999-4923/14/7/1408

Internet

https://www.mdpi.com/1999-4923/14/7/1408

Similar Items